Analysis of tumor-infiltrating lymphocytes (TILs) implicated that anti-CTLA4 predominantly mediated a decrease in the Treg compartment, whereas anti-PD-L1 promoted a strong increase in CD8+ TILs. The gene discussed is CD8A; the disease is neoplasm.